Calretinin Expression in Human Normal and Neoplastic Tissues: A Tissue Microarray Analysis on 5233 Tissue Samples

Human Pathology

Volumn 34, Issue 10, 2003, Pages 994-1000

  Lugli, Alessandro ^a   Forster, Yvonne ^a   Haas, Philippe ^a   Nocito, Antoinio ^a   Bucher, Christoph ^a   Bissig, Heidi ^a   Mirlacher, Martina ^a   Storz, Martina ^a   Mihatsch, Michael J ^a   Sauter, Guido ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Calretinin; Human tumor; Normal tissue; Tissue microarray

Indexed keywords

CALCIUM BINDING PROTEIN; CALRETININ; TUMOR MARKER;

ADENOMATOID TUMOR; ADRENAL CORTEX CARCINOMA; ARTICLE; BRAIN NERVE CELL; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; LEYDIG CELL TUMOR; LUNG ADENOCARCINOMA; MALIGNANT MESOTHELIOMA; METASTASIS; PROTEIN EXPRESSION; THECA CELL;

EID: 0142200879     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/S0046-8177(03)00339-3     Document Type: Article

References (36)

1. Rogers JH: Calretinin: A gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol 105:1343-1353, 1987
2. Parmentier M, Lefort A: Structure of the human brain calcium-binding protein calretinin and its expression in bacteria. Eur J Biochem 196:79-85, 1991
3. Rogers J, Khan M, Ellis J: Calretinin and other CaBPs in the nervous system. Adv Exp Med Biol 269:195-203, 1990
4. Andressen C, Blumcke I, Celio MR: Calcium-binding proteins: Selective markers of nerve cells. Cell Tissue Res 271:181-208, 1993
5. Bertschy S, Genton CY, Gotzos V: Selective immunocytochemical localization of calretinin in the human ovary. Histochem Cell Biol 109:59-66, 1998
6. Afework M, Burnstock G: Calretinin immunoreactivity in adrenal glands of developing, adult and aging Sprague-Dawley rats. Int J Dev Neurosci 13:515-521, 1995
7. Gangji V, Krebs C, Rooze M, et al: Calretinin is transiently expressed in tendon fibroblasts of the paravertebral region of the chick embryo. Eur J Morphol 35:137-142, 1997
8. Strauss KI, Isaacs KR, Ha QN, et al: Calretinin is expressed in the Leydig cells of rat testis. Biochim Biophys Acta 1219:435-440, 1994
9. Kiraly E, Celio MR: Paravalbumin and calretinin in the avian thymus. Anat Embryol (Berl) 188:339-344, 1993
10. Gotzos V, Vogt P, Celio MR: The calcium-binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 192:137-147, 1996
11. Ordonez NG: Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Mod Pathol 11:929-933, 1998
12. Oates J, Edwards C: HBME-1, MOC-31, WT1 and calretinin: An assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 36:341-347, 2000
13. Cury PM, Butcher DN, Fisher C, et al: Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 13:107-112, 2000
14. Chenard-Neu MP, Kabou A, Mechine A, et al: Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma. Evaluation of 5 new antibodies and 6 traditional antibodies. Ann Pathol 18:460-465, 1998
15. Carella R, Deleonardi G, D'Errico A, et al: Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: A study with logistic regression analysis. Am J Surg Pathol 25:43-50, 2001
16. Brockstedt U, Gulyas M, Dobra K, et al: An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 114:203-209, 2000
17. Gotzos V, Wintergerst ES, Musy JP, et al: Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues. Am J Surg Pathol 23:701-711, 1999
18. Matsuno Y, Morozumi N, Hirohashi S, et al: Papillary carcinoma of the thymus: Report of four cases of a new microscopic type of thymic carcinoma. Am J Surg Pathol 22:873-880, 1998
19. Altini M, Coleman H, Doglioni C, et al: Calretinin expression in ameloblastomas. Histopathology 37:27-32, 2000
20. Zamboni G, Scarpa A, Bogina G, et al: Mucinous cystic tumors of the pancreas: Clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 23:410-422, 1999
21. Terracciano LM, Mhawech P, Suess K, et al: Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol 114:754-759, 2000
22. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
23. Bubendorf L, Nocito A, Moch H, et al: Tissue microarray (TMA) technology: Miniaturized pathology archives for high-throughput in situ studies. J Pathol 195:72-79, 2001
24. Schraml P, Kononen J, Bubendorf L, et al: Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5:1966-1975, 1999
25. Moch H, Schraml P, Bubendorf L, et al: High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154:981-986, 1999
26. Nocito A, Bubendorf L, Maria Tinner E, et al: Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 194:349-357, 2001
27. Torhorst J, Bucher C, Kononen J, et al: Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159:2249-2256, 2001
28. Bucher C, Torhorst J, Kononen J, et al: Automated, high-throughput tissue microarray analysis for assessing the significance of Her-2 involvement in breast cancer. (Abstract) Proceedings of the American Society of Clinical Oncology annual meeting. New Orleans, LA, 2000
29. Simon R, Richter J, Wagner U, et al: High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res 61:4514-4519, 2001
30. Simon R, Eltze E, Schafer KL, et al: Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 61:355-362, 2001
31. Nagel H, Hemmerlein B, Ruschenburg I, et al: The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology. Pathol Res Pract 194:759-764, 1998
32. Barberis MC, Faleri M, Veronese S, et al: Calretinin: A selective marker of normal and neoplastic mesothelial cells in serous effusions. Acta Cytol 41:1757-1761, 1997
33. Cao QJ, Jones JG, Li M: Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol 20:346-352, 2001
34. Roberts F, Harper CM, Downie I, et al: Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma: A study of thirteen antibodies. Am J Clin Pathol 116:253-262, 2001
35. Doglioni C, Tos AP, Laurino L, et al: Calretinin: A novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 20:1037-1046, 1996
36. Attanoos RL, Dojcinov SD, Webb R, et al: Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms. Histopathology 37:224-231, 2000